NYSE MKT LLC · KAPA
+3.06% · +$0.0110 · Vol 44.6K
Market closed · last close 4:00 PM ET · price as of 20:00:00 ET
Kairos Pharma Ltd

Kairos Pharma Ltd

Biotechnology
$0.3700
+ Add to watchlist
Card

Veridion Score

Refresh
Score snapshot refresh in progress
Veridion Score History · 90D

Composite trend over time

HISTORY REFRESH IN PROGRESS
REFRESHES DAILY
AI Analysis
Sovereign

Why is KAPA moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Catalyst calendar
Dated receipts for KAPA are being assembled.
About Kairos Pharma Ltd
PHARMACEUTICAL PREPARATIONS
Listed since
2024
Employees
1
Country
US

Kairos Pharma Ltd is a clinical-stage biopharmaceutical company. The company is engaged in therapeutics for cancer patients that are designed to overcome key hurdles in immune suppression and drug resistance. These therapeutics include antibodies and small molecules for the treatment of prostate cancer, lung cancer, breast cancer, and glioblastoma. The product portfolio of the company consists of Pre-clinical or clinical-trial stage drug candidates, Therapeutic agents, and other technologies for treating diseases.

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$0.3619
Day high
$0.3882
Day low
$0.3500
Previous close
$0.3590
52W high
$0.4580
-19.21% from high
52W low
$0.3260
33% of range
Market cap
$7.7M
EPS
$-0.3100
Shares out
21.4M
Volume
44.6K
VWAP
$0.3644
Price history computed in-house
1W
-7.50%
1M
-17.74%
SMA 50 $0.4051 · below
SMA 200 $0.4051 · below
52W position 33%
Veridion warehouse edge

Warehouse intelligence for KAPA.

Veridion Score
44
0: 891: 482: 283: 204: 785: Not reported
Congress 30d
0
No recent disclosure on file.
Insider activity
See Form 4 panel below.
13F holders
None on file
Capital Web snapshots checked.
Disclosure-sourced lobbying and contract detail remains attributed in the full panels below.
Data ledger
Quote and day range
Refresh interval: 30 seconds
Source: Market data
Veridion Score
Coverage building
Source: Veridion methodology
Chart and risk context
Daily bars with no missing-bar fill
Source: Market data
News and filings
Refresh intervals shown inside each panel
Source: Market news and federal filings
Financials
Statements refresh in progress
SEC Form 4 ledger

KAPA insider activity

Kairos Pharma Ltd

Score
Coverage building
Pressure
Mixed
Filings
0
Buys / sells
0 / 0
Net value
Not disclosed
Insiders
0
Cluster

No multi-insider buying cluster in the last 90 days

Net pressure

Mixed: Not disclosed across loaded Form 4 rows.

Convergence not established

Loaded official disclosures do not show all three sources aligned on this ticker.

Coverage building

The current Form 4 feed did not return value-bearing open-market rows for KAPA.

Source: SEC EDGAR Form 4. Rows with missing price or quantity are excluded rather than zero-filled.Methodology
Congress · 90D
Congress filing snapshot refresh in progress
Federal contracts

KAPA contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for KAPA in this window.
Lobbying spend

KAPA lobbying filings, year to date.

Registered lobbying filings matched to Kairos Pharma Ltd.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for KAPA in this window.
Latest news · KAPA
Refresh interval: 5 minutes · Source: Market news insights
News snapshot refresh in progress
Analyst ratings
Sovereign unlock shows live analyst consensus for KAPA.
Options
Sovereign unlock shows live options positioning for KAPA.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.